Literature DB >> 9773963

Impact of assay parameters on the accuracy of free PSA test: source and stability of calibrator, calibration curve fitting, and level of total PSA in the serum.

G H Liu1, J T Wu.   

Abstract

The measurement of PSA is recommended for men over 50 years of age for screening of prostate cancer. However, proper differentiation of prostate cancer from benign prostate hyperplasia (BPH) relies on an accurate measurement of free PSA (fPSA) and a correct calculation of percent fPSA. Because of the extremely low concentration of fPSA in the serum, any slight deviation from its true value may produce large errors in percent fPSA calculated. Therefore, we undertook a study examining carefully those parameters of the fPSA assay which might affect the fPSA determination. We found that the integrity of the calibrator, the computer curve-fitting program selected, the source of the calibrator, and the total PSA or fPSA + PSA complexes (tPSA) concentration of the specimen all had an impact on the accuracy of the fPSA value assayed. We found that an examination of the slope of the calibration curve was important to reveal whether the calibrator had or had not been denatured during storage. We also found that the 4-parameter cure fitting program was best suited for plotting the fPSA calibration curve. The calibrator we isolated from LNCaP cells was acceptable for our assay because it had an affinity for the assay antibody very similar to that of serum fPSA. We also determined the effect of tPSA concentration on the fPSA determinations and found that within the concentration range of 4-10 ng/mL the impact on the percent fPSA calculated was not significant. We believe that our assay produces accurate fPSA values when all these assay parameters are well controlled.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9773963      PMCID: PMC6807898     

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  12 in total

1.  Serum prostate-specific antigen assay--an update.

Authors:  J T Wu
Journal:  West J Med       Date:  1995-05

2.  Production of milligram concentrations of free prostate specific antigen (fPSA) from LNCaP cell culture: difference between fPSA from LNCaP cell and seminal plasma.

Authors:  J T Wu; B W Lyons; G H Liu; L L Wu
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

3.  Monitoring percent free PSA in serial specimens: improvement of test specificity, early detection, and identification of occult tumors.

Authors:  J T Wu; G H Liu; P Zhang; R A Stephenson
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

4.  The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population.

Authors:  C H Bangma; J B Rietbergen; R Kranse; B G Blijenberg; K Petterson; F H Schröder
Journal:  J Urol       Date:  1997-06       Impact factor: 7.450

5.  The fitting, acceptance, and processing of standard curve data in automated immunoassay systems, as exemplified by the Serono SR1 analyzer.

Authors:  P B Daniels
Journal:  Clin Chem       Date:  1994-04       Impact factor: 8.327

6.  Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin.

Authors:  H Lilja; A Christensson; U Dahlén; M T Matikainen; O Nilsson; K Pettersson; T Lövgren
Journal:  Clin Chem       Date:  1991-09       Impact factor: 8.327

Review 7.  Prostate specific antigen predominantly forms a complex with alpha 1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum.

Authors:  H Lilja; A T Cockett; P A Abrahamsson
Journal:  Cancer       Date:  1992-07-01       Impact factor: 6.860

Review 8.  Assay for prostate specific antigen (PSA): problems and possible solutions.

Authors:  J T Wu
Journal:  J Clin Lab Anal       Date:  1994       Impact factor: 2.352

9.  Evaluation of free PSA isoforms, PSA complex formation, and specificity of anti-PSA antibodies by HPLC and PAGE-immunoblotting techniques.

Authors:  J T Wu; P Zhang; T Wang; L Wilson; M Astill
Journal:  J Clin Lab Anal       Date:  1995       Impact factor: 2.352

10.  Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.

Authors:  W J Catalona; D S Smith; R L Wolfert; T J Wang; H G Rittenhouse; T L Ratliff; R B Nadler
Journal:  JAMA       Date:  1995-10-18       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.